Guidance for NIH-Funded Clinical Trials and Human Subjects Studies Affected by COVID-19

NIH recognizes the significant effects that this emergency is having on NIH-funded clinical trials and other human subjects studies. For details on expanded flexibilities, such as mid-project period extensions and administrative supplements for unanticipated costs, see NOT-OD-20-087.

Share
  •  
  •  
  •  
  •   
  •  

2 thoughts on “Guidance for NIH-Funded Clinical Trials and Human Subjects Studies Affected by COVID-19

Leave a Reply

Your email address will not be published. Required fields are marked *